NL7502952A - Vast therapeutisch preparaat voor inwendig gebruik. - Google Patents

Vast therapeutisch preparaat voor inwendig gebruik.

Info

Publication number
NL7502952A
NL7502952A NL7502952A NL7502952A NL7502952A NL 7502952 A NL7502952 A NL 7502952A NL 7502952 A NL7502952 A NL 7502952A NL 7502952 A NL7502952 A NL 7502952A NL 7502952 A NL7502952 A NL 7502952A
Authority
NL
Netherlands
Prior art keywords
internal use
therapeutic preparation
solid therapeutic
solid
preparation
Prior art date
Application number
NL7502952A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NL7502952A publication Critical patent/NL7502952A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
NL7502952A 1974-03-12 1975-03-12 Vast therapeutisch preparaat voor inwendig gebruik. NL7502952A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (nl) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
NL7502952A true NL7502952A (nl) 1975-09-16

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7502952A NL7502952A (nl) 1974-03-12 1975-03-12 Vast therapeutisch preparaat voor inwendig gebruik.

Country Status (12)

Country Link
US (1) US3976764A (nl)
JP (1) JPS5512411B2 (nl)
BE (1) BE826498A (nl)
CA (1) CA1054056A (nl)
CH (1) CH604719A5 (nl)
DE (1) DE2510620C2 (nl)
DK (1) DK142802B (nl)
ES (1) ES435500A1 (nl)
FR (1) FR2263744B1 (nl)
GB (1) GB1507521A (nl)
NL (1) NL7502952A (nl)
SE (1) SE409286B (nl)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
EP0083372B1 (en) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Sustained release theophyline
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (nl) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
CA2085585A1 (en) * 1990-06-25 1991-12-26 George Torosian Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (nl) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
EP2332522A3 (en) 1998-03-19 2011-12-07 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
BRPI0407438A (pt) * 2003-02-21 2006-02-07 Lek Pharmaceuticals Sistema terapêutico compreendendo amoxicilina e ácido clavulânico
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
EP2068844A4 (en) * 2006-09-04 2013-01-23 Panacea Biotec Ltd PROGRAMMABLE RELEASE TECHNIQUE BY FLOATING SYSTEM
WO2009087665A2 (en) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Novel gastroretentive drug delivery system
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
WO2011004799A1 (ja) * 2009-07-06 2011-01-13 杏林製薬株式会社 中空構造を有する錠剤
EP2590633B1 (en) * 2010-07-05 2017-10-11 Jagotec AG Dosage form
EP2731609A1 (en) * 2011-07-14 2014-05-21 APeT Holding B.V. Nicotinamide compositions and the therapeutic use thereof
CA2851765C (en) 2011-10-11 2017-08-15 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
MX2015000760A (es) * 2012-07-16 2015-09-10 Apet Holding B V Sistema de suministro de farmaco gastro - retentivo.
EP2719376B1 (en) 2012-10-12 2015-03-04 Omya International AG Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
CN106573015B (zh) 2014-06-11 2021-11-26 麻省理工学院 肠溶弹性体
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
CN107592803B (zh) 2015-05-01 2021-01-22 麻省理工学院 可触发形状记忆感应装置
EP3364946A4 (en) 2015-10-23 2019-06-26 Lyndra, Inc. STOMACH DISTRIBUTION SYSTEMS FOR DELAYED RELEASE OF THERAPEUTIC ACTIVE SUBSTANCES AND METHOD FOR THEIR USE
JP2019512468A (ja) * 2016-03-18 2019-05-16 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 浮遊性の薬学的剤形
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
WO2018064630A1 (en) 2016-09-30 2018-04-05 Lyndra, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
SE7502725L (nl) 1975-09-13
DK97875A (nl) 1975-09-13
US3976764A (en) 1976-08-24
BE826498A (fr) 1975-06-30
ES435500A1 (es) 1977-02-01
FR2263744B1 (nl) 1978-11-24
JPS5512411B2 (nl) 1980-04-02
DE2510620A1 (de) 1975-09-18
CH604719A5 (nl) 1978-09-15
JPS50121418A (nl) 1975-09-23
CA1054056A (en) 1979-05-08
DE2510620C2 (de) 1984-01-05
SE409286B (sv) 1979-08-13
FR2263744A1 (nl) 1975-10-10
GB1507521A (en) 1978-04-19
DK142802C (nl) 1981-09-21
DK142802B (da) 1981-02-02

Similar Documents

Publication Publication Date Title
NL7502952A (nl) Vast therapeutisch preparaat voor inwendig gebruik.
SE427752B (sv) Forfarande for framstellning n-fosfonometylglycin
SE7507414L (sv) Galenisk beredning.
NL7514012A (nl) Farmaceutische capsules.
NL7501917A (nl) Farmaceutisch preparaat en heterocyclische verbinding alsmede werkwijze voor het bereiden daarvan.
NL7511598A (nl) Voorgaren en werkwijze voor het vervaardigen ervan.
NL7510478A (nl) Werkwijze voor de bereiding van multiheteromacro- ringverbindingen.
NL7500552A (nl) Farmaceutische preparaten.
NL7507298A (nl) Werkwijze voor de bereiding van terpolymeren.
NL7402008A (nl) Voorbehoedmiddel.
NL7508829A (nl) Werkwijze voor de bereiding van aldehyden.
NL7505240A (nl) Farmaceutisch preparaat.
NL7503055A (nl) Werkwijze ter bereiding van therapeutische preparaten.
BE836826A (fr) Automatische modulatiebandegalisator voor datatransmissiesystemen
NO146199C (no) Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid
BE836589A (fr) Signaalverdeelinrichting voor een kabeltelevisienetwerk
NL7611088A (nl) N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan.
NL7500600A (nl) Voedselbereidingsinrichting voor huishoudelijk gebruik.
NL7500305A (nl) Werkwijze voor de bereiding van poly-alkeen- llietaatimiden.
BE820781A (fr) Deksels voor houders
BE830726A (nl) Lokmiddel voor mieren
NL7505174A (nl) Farmaceutische mengsels.
BE812477A (fr) Inspektieput voor rioleringssystemen
NL7312095A (nl) Inrichting voor ademhalingsonderzoek.
NL7512624A (nl) Werkwijze voor de octeennitrileverbindingen.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed